| Microbiologically documented infections after adult allogeneic hematopoietic cell transplantation: A 5-year analysis within the Swiss Transplant Cohort study | Transplant Infectious Disease |  | | 2020 | 409 | 2 |
|
| A dose-dependent plasma signature of the safety and immunogenicity of the rVSV-Ebola vaccine in Europe and Africa | Science Translational Medicine | | | 2017 | 641 | 2 |
|
| Volunteer feedback and perceptions after participation in a phase I, first-in-human Ebola vaccine trial: An anonymous survey | PLOS ONE |  | | 2017 | 516 | 240 |
|
| Clinical Management of Ebola Virus Disease in the United States and Europe | New England Journal of Medicine | | | 2016 | 1,232 | 372 |
|
| Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe : Preliminary Report | The New England journal of medicine | | | 2016 | 938 | 302 |
|
| Ebola Virus Disease Complications as Experienced by Survivors in Sierra Leone | Clinical infectious diseases | | | 2016 | 647 | 505 |
|
| The 2014–2015 Ebola outbreak in West Africa: Hands On | Antimicrobial Resistance and Infection Control | | | 2016 | 550 | 275 |
|
| The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial | Lancet. Infectious diseases | | | 2015 | 710 | 0 |
|
| Ebola: le point au crépuscule d'une épidémie inattendue | Revue médicale suisse | | | 2015 | 144 | 346 |
|
| Clinical features and viral kinetics in a rapidly cured patient with Ebola virus disease: a case report | Lancet. Infectious diseases | | | 2015 | 717 | 1 |
|
